한국의 임산부에서 실험실에서 확인된 SARS-CoV-2 감염에 따른 임상 양상 및 산모와 신생아의 결과
Clinical Manifestations and Maternal and Perinatal Outcomes in Pregnancy Following Laboratory-Confirmed SARS-CoV-2 Infection in South Korea
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: To determine the clinical manifestations and maternal and perinatal outcomes in pregnant women with coronavirus disease 2019 (COVID-19). Methods: We conducted a retrospective observational study of pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who were admitted to National Health Insurance Service (NHIS) Ilsan Hospital between August 2020 and October 2021. The maternal and perinatal outcomes were investigated. Results: Among 184 pregnant women infected with SARS-CoV-2, 79 women delivered. Of the women who delivered, with 36 women giving birth during the quarantine period. At delivery, 45 women were positive for SARS-CoV-2 by polymerase chain reaction (PCR), whereas 34 women were negative. The most common clinical manifestations were cough (65.2%), fever (38.0%), and myalgia (33.2%). Regarding perinatal outcomes, none of the babies had an Apgar score < 7 at 5 minutes, and none were intubated following the delivery. The preterm birth rate and small-for-gestational-age (SGA) rate were 15.2% and 16.5%, respectively. All babies who was delivered at NHIS Ilsan Hospital were negative for SARSCoV- 2 infection by PCR, which was evaluated using amniotic fluid, cord blood, neonatal nasopharyngeal and oropharyngeal swabs in the 1st and 2nd days following delivery, although 45 women were positive for SARS-CoV-2 infection by PCR at the time of delivery. Conclusion: Most pregnant women with COVID-19 in South Korea were unlikely to manifest symptoms or present with a severe disease progression. The observed preterm birth rate and SGA rate were higher in women with COVID-19 than in those without COVID-19. However, there was no evidence of vertical transmission, and all babies were negative for SARS-CoV-2 infection during pregnancy.
Abstract
Purpose: To determine the clinical manifestations and maternal and perinatal outcomes in pregnant women with coronavirus disease 2019 (COVID-19). Methods: We conducted a retrospective observational study of pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who were admitted to National Health Insurance Service (NHIS) Ilsan Hospital between August 2020 and October 2021. The maternal and perinatal outcomes were investigated. Results: Among 184 pregnant women infected with SARS-CoV-2, 79 women delivered. Of the women who delivered, with 36 women giving birth during the quarantine period. At delivery, 45 women were positive for SARS-CoV-2 by polymerase chain reaction (PCR), whereas 34 women were negative. The most common clinical manifestations were cough (65.2%), fever (38.0%), and myalgia (33.2%). Regarding perinatal outcomes, none of the babies had an Apgar score < 7 at 5 minutes, and none were intubated following the delivery. The preterm birth rate and small-for-gestational-age (SGA) rate were 15.2% and 16.5%, respectively. All babies who was delivered at NHIS Ilsan Hospital were negative for SARSCoV- 2 infection by PCR, which was evaluated using amniotic fluid, cord blood, neonatal nasopharyngeal and oropharyngeal swabs in the 1st and 2nd days following delivery, although 45 women were positive for SARS-CoV-2 infection by PCR at the time of delivery. Conclusion: Most pregnant women with COVID-19 in South Korea were unlikely to manifest symptoms or present with a severe disease progression. The observed preterm birth rate and SGA rate were higher in women with COVID-19 than in those without COVID-19. However, there was no evidence of vertical transmission, and all babies were negative for SARS-CoV-2 infection during pregnancy.
참고문헌 (25)
- Allotey J, "Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy : living systematic review and meta-analysis", BMJ, 370, pp.m3320~ (2020)
- Badr DA, "Are clinical outcomes worse for pregnant women at ≥20 weeks' gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching", Am J Obstet Gynecol, 223, pp.764~768 (2020)
- Dawood FS, "Incidence and clinical characteristics of and risk factors for severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection among pregnant individuals in the United States", Clin Infect Dis, pp.ciab713~ (2021)[DOI]
- Doubilet PM, "Improved birth weight table for neonates developed from gestations dated by early ultrasonography", J Ultrasound Med, 16, pp.241~249 (1997)
- Goh XL, "Incidence of SARSCoV-2 vertical transmission : a meta-analysis", Arch Dis Child Fetal Neonatal Ed, 106, pp.112~113 (2021)
- Hantoushzadeh S, "Maternal death due to COVID-19", Am J Obstet Gynecol, 223, pp.109.e1~109.e16 (2020)
- Huntley BJF, "Adverse pregnancy outcomes among individuals with and without severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) : a systematic review and meta-analysis", Obstet Gynecol, 137, pp.585~596 (2021)
- Joseph NT, "Coronavirus disease 2019(COVID-19)and pregnancy outcomes : state of the science", Obstet Gynecol, 138, pp.539~541 (2021)
- Kirtsman M, "Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection", CMAJ, 192, pp.E647~E650 (2020)
- Knight M, "Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK : national population based cohort study", BMJ, 369, pp.m2107~ (2020)
- Kotlyar AM, "Vertical transmission of coronavirus disease 2019 : a systematic review and meta-analysis", Am J Obstet Gynecol, 224, pp.35~53.e3 (2021)
- Lokken EM, "Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State", Am J Obstet Gynecol, 225, pp.77.e1~77.e14 (2021)
- Lokken EM, "Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State", Am J Obstet Gynecol, 223, pp.911.e1~911.e14 (2020)
- Metz TD, "Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications", JAMA, 327, pp.748~759 (2022)
- Metz TD, "Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019(COVID-19)", Obstet Gynecol, 137, pp.571~580 (2021)
- Mullins E, "Pregnancy and neonatal outcomes of COVID-19 : coreporting of common outcomes from PANCOVID and AAP-SONPM registries", Ultrasound Obstet Gynecol, 57, pp.573~581 (2021)
- Panagiotakopoulos L, "SARS-CoV-2 infection among hospitalized pregnant women : reasons for admission and pregnancy characteristics-eight U. S. Health Care Centers, March 1-May 30, 2020", MMWR Morb Mortal Wkly Rep, 69, pp.1355~1359 (2020)
- Pierce-Williams RAM, "Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies : a United States cohort study", Am J Obstet Gynecol MFM, 2, pp.100134~ (2020)
- Pineles BL, "In-hospital mortality in a cohort of hospitalized pregnant and nonpregnant patients with COVID-19", Ann Intern Med, 174, pp.1186~1188 (2021)
- Shah PS, "Preterm birth and stillbirth rates during the COVID-19 pandemic : a population-based cohort study", CMAJ, 193, pp.E1164~E1172 (2021)
- Von Kohorn I, "In utero severe acute respiratory syndrome coronavirus 2 infection", J Pediatric Infect Dis Soc, 9, pp.769~771 (2020)
- Wiersinga WJ, "Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019(COVID-19) : a review", JAMA, 324, pp.782~793 (2020)
- Woodworth KR, "Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy-SET-NET, 16 Jurisdictions, March 29-October 14, 2020", MMWR Morb Mortal Wkly Rep, 69, pp.1635~1640 (2020)
- Yanes-Lane M, "Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential : a systematic review and metaanalysis", PLoS One, 15, pp.e0241536~ (2020)
- Zambrano LD, "Update : Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States, January 22-October 3, 2020", MMWR Morb Mortal Wkly Rep, 69, pp.1641~1647 (2020)